Doxefazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401506This classification denotes a benzodiazepine with the molecular formula C17H14ClFN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 231RV72C8L, chemically known as 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-3-hydroxy-1-(2-hydroxyethyl)-2h-1,4-benzodiazepin-2-one but generally known as doxefazepam, which bears US NIH Compound Identifier 38668. European Medicines Agency schedules Doxefazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06385MIG. The term DOXEFAZEPAM is an International Non-Proprietary Name. World Health Organization schedules doxefazepam in its Anatomical Therapeutic Chemical (ATC) Classification. DOXEFAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxefazepam under HS 29339940 and SITC 51577. As of Q4 2014, DOXEFAZEPAM remains the US FDA Preferred Term for this commodity. Doxefazepam bears US NLM identifiers UMLS ID C0114875 and NCI Concept Code C65474. SMILES: CLC1CC2C(N(CCO)C(=O)C(O)N=C2C2C(F)CCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.